Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 03, 2018
BrainStorm Cell Therapeutics has received GMP approval from the Israel Ministry of Health for its Israeli contract manufacturing facility.
read more
BrainStorm has begun training City of Hope's Center for Biomedicine and Genetics to produce NurOwn adult stem cells for the ALS Phase 3 clinical study.
read more
Thursday, September 27, 2018
Brammer Bio announces that a three-year, $200 million investment program is on track to establish over 30 suites for clinical and commercial viral vector supply for a broad pipeline of advanced gene therapies and gene-modified cell therapies.
read more
Monday, September 18, 2017
Brammer Bio announced completion of its clinical capacity expansion in Alachua, Florida.
read more
Brammer Biopharmaceuticals has announced its merger with Florida Biologix to create a cell and gene therapy biologics contract development and manufacturing organization (CDMO). The merged company, Brammer Bio, will combine deep technical expertise ...
read more
Monday, November 27, 2017
Brammer Bio announced the completion of renovations and launch of its late-stage clinical capacity and commercial-ready cGMP manufacturing site in Cambridge, Massachusetts for gene therapy products.
read more
Friday, February 27, 2015
Brazil, a signature country of South America just surpassed 200 million residents. It is the main economy in Latin America and one of the most important at world level, regionally considered industrialized in spite of the variety of income, from very...
read more
Wednesday, October 04, 2017
Breckenridge Pharmaceutical has acquired five Abbreviated New Drug Applications (ANDAs) from Nostrum Laboratories.
read more
Breckenridge Pharmaceutical, the U.S. subsidiary of Towa International, announced a partnership with Maiva Pharma focused on sterile injectable products to be supplied primarily to hospitals and clinics.
read more
Breckenridge announced it has entered into a multi-product agreement with Sam Chun Dang Pharm, under which Breckenridge and SCD expect to develop and commercialize at least seven ANDAs.
read more
Breckenridge Pharmaceutical, Inc. announced the signing of a multi-product agreement with Aggrega Pharma, LLC. under which Aggrega will develop, manufacture and supply pharmaceutical products for marketing, sale and distribution by Breckenridge.
read more
Breckenridge Pharmaceutical, Inc. has signed a new-product agreement with PTS Pharma, LLC. under which PTS will support a technology transfer to Towa Pharmaceutical Europe, S.L. of a complex "For Suspension" product developed by PTS.
read more
Thursday, January 16, 2020
BrevisRefero announces the official launch of its innovative online Request For Proposal (RFP) platform.
read more
Thursday, August 22, 2013
Modality Solutions, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, is pleased to announce Principal Brian Wallin was named a 2013 Top Rising Star in Temperature Controlled Logistics ...
read more
Wednesday, January 22, 2020
BridgeBio Pharma announced a collaboration agreement with Catalent to establish dedicated gene therapy development and manufacturing capacity at Catalent’s Paragon Gene Therapy clinical and commercial manufacturing center.
read more